Raleigh Capital Management’s West Pharmaceutical WST Stock Holding History

Raleigh Capital Management’s Portfolio WST Stock Details WST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-9	Closed	-$2.26K	–	771
2026 Q1	$2.26K	Buy	+9	New	+$2.24K	﹤0.01%	508
2025 Q2	–	Sell	-3	Closed	-$672	–	711
2025 Q1	$672	Sell	3 -19	-86%	-$5.24K	﹤0.01%	472
2024 Q4	$7.21K	Buy	22 +1	+5%	+$315	﹤0.01%	660
2024 Q3	$6.3K	Buy	21 +14	+200%	+$4.29K	﹤0.01%	668
2024 Q2	$2.31K	Sell	7 -1	-13%	-$353	﹤0.01%	768
2024 Q1	$3.17K	Sell	8 -81	-91%	-$30K	﹤0.01%	713
2023 Q4	$31.4K	Buy	89 +7	+9%	+$2.48K	0.01%	351
2023 Q3	$30.8K	Buy	82 +2	+3%	+$773	0.02%	320
2023 Q2	$30.6K	Buy	+80	New	+$28.6K	0.02%	303

Other funds holding WST

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

GIM

Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Raleigh Capital Management's WST Position: Q2 2026 in Review

Raleigh Capital Management sold out of West Pharmaceutical (WST) in Q2 2026, closing a stake of 9 shares — an estimated $2.26K sold.

Raleigh Capital Management first reported a position in WST in Q2 2023 and held it in 9 quarters. The position peaked at $31.4K in Q4 2023. 834 funds tracked by Wall St. Rank hold WST as of Q2 2026.

Raleigh Capital Management reported no remaining West Pharmaceutical position as of Q2 2026 after selling out during the quarter.
Raleigh Capital Management sold 9 West Pharmaceutical shares in Q2 2026, an estimated $2.26K.
Raleigh Capital Management first reported a position in West Pharmaceutical in Q2 2023 and held it in 9 quarters.
Raleigh Capital Management's West Pharmaceutical position peaked at $31.4K in Q4 2023.
834 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Raleigh Capital Management's 13F filing for Q2 2026, filed 21 Jul 2026.